Send a text

AI ambition isn’t the problem in healthcare. Execution is.

In this episode of The Signal Room, Chris Hutchins sits down with Brian Sutherland, Lead AI Product Manager and advisor specializing in customer-facing AI for high-consequence healthcare environments.

Brian built Humana’s first member-facing Intelligent Virtual Assistant — generating $7M+ in annual savings while improving patient experience and task completion. In this conversation, we move beyond AI hype and examine what actually breaks between executive strategy and operational reality.

We explore:

• Why AI pilots succeed but enterprise adoption stalls
• Trust as infrastructure — not philosophy
• The leadership shift required as AI embeds into clinical workflows
• Where hype is outrunning evidence in healthcare AI
• What responsible scale actually looks like

If you are a healthcare executive, board member, digital health leader, or AI product owner, this episode is a grounded discussion on what it takes to move from ambition to accountable execution.

Connect with Brian Sutherland on LinkedIn:
https://www.linkedin.com/in/briandsutherland/

Subscribe for practical conversations at the intersection of leadership, ethics, and healthcare innovation.

Support the show

Send a text

AI is transforming drug discovery—but faster models alone do not get drugs approved.

In this episode of The Signal Room, host Chris Hutchins speaks with David Finkelshteyn, CEO of Pivotal AI, about why verification—not speed or model accuracy—is the real bottleneck in pharmaceutical AI.

David explains why generating AI-designed molecules without rigorous validation creates more risk than value, especially in regulated environments like pharma and healthcare. The conversation breaks down where AI outputs most often fail between discovery and regulatory acceptance, why black-box models struggle under scrutiny, and what it actually means to verify an AI insight in drug development.

They also explore practical challenges around data integrity, auditability, missing context, hallucinations, and the growing use of consumer AI tools in health decisions. Rather than chasing hype, this episode focuses on how AI can responsibly accelerate drug development by failing faster, tightening verification loops, and building systems that can be defended to regulators, auditors, and clinicians.

This episode is essential listening for leaders working in pharmaceutical R&D, healthcare AI, data science, AI governance, and regulated technology environments.

Guest: David Finkelshteyn, CEO, Pivotal AI
LinkedIn: https://www.linkedin.com/in/david-finkelshteyn-03191a130/

Support the show

Send a text

This episode explores ethical leadership and AI governance challenges in healthcare cybersecurity, emphasizing the risks of undetected breaches.'

In this episode of The Signal Room, Chris Hutchins speaks with Guman Chauhan, a cybersecurity and risk leader, about one of the most dangerous conditions in modern organizations: being breached and not knowing it. While dashboards stay green and alerts stay quiet, attackers increasingly operate using valid credentials, normal behavior patterns, and long dwell times—remaining invisible for weeks or months.

Guman explains why “no alerts” is often mistaken for “no breach,” and why silence is one of the most misleading signals in cybersecurity. The conversation unpacks how attackers deliberately avoid detection, why security tools alone do not equal security outcomes, and where organizations create blind spots through untested assumptions, alert fatigue, and fragmented processes.

They explore why undetected breaches are more damaging than known ones, how time compounds risk once attackers are inside, and what separates organizations that mature after incidents from those that repeat the same failures. Guman emphasizes that proven security is not built on policies, certifications, or dashboards—but on continuous testing, validated detection, and teams that know how to act under pressure.

This episode is a practical guide for executives, security leaders, healthcare organizations, and regulated enterprises that need to move from assumed security to proven breach readiness.

Guest: Guman Chauhan
LinkedIn: https://www.linkedin.com/in/guman-chauhan-m-s-cissp-cism-600824103/

Topics Covered

• Why undetected breaches are more dangerous than known breaches
• How attackers use valid credentials to avoid detection
• Why “no alerts” does not mean “no breach”
• Alert fatigue and the signal-to-noise problem
• Security tools vs security outcomes
• Visibility gaps, unknown assets, and logging failures
• External penetration testing and real-world validation
• Cultural and leadership factors in breach response
• Assumed security vs proven security

Key Takeaways

• Silence is not security; it often means you are not seeing the right signals.
• Most breaches go undetected because attackers behave like legitimate users.
• Security tools do not fail—untested assumptions do.
• Alert fatigue hides real risk by normalizing noise.
• Proven security requires testing detection and response end to end.
• Mature organizations treat breaches as learning moments, not events to hide.
• Confidence without validation creates the most dangerous blind spots.

Chapters / Timestamps

00:00 – Why undetected breaches are the real risk
02:30 – Being breached vs being breached and not knowing
06:00 – How attackers stay invisible using valid credentials
08:30 – Why dashboards and alerts create false confidence
10:00 – Common reasons breaches go undetected for months
13:30 – Security tools vs security outcomes
16:00 – Technology, process, and people failures
19:30 – Alert fatigue and finding real signals
22:30 – Why external penetration testing still matters
26:30 – What mature organizations do after a breach
31:00 – One action to improve breach readiness this year
32:45 – The uncomfortable question every leader should ask
34:30 – Assumed security vs proven security
36:30 – How to connect with Guman & closing

Support the show